SlideShare uma empresa Scribd logo
1 de 26
Combined Data Interchange Standard
Consortium (CDISC)
Standard Data Tabulation Model
Presented By:
Ankur Sharma
Biostatistical Programmer
PAREXEL International,
Baltimore, MD, USA
Definitions
 CDISC : Clinical Data Interchange Standard Consortium
 SDTM : Standard Data Tabulation Model
 ADaM : Analysis Data Model
 SDS : Submission Data Standards
 DDT : Data Definition Tables
Clinical Data Interchange Standard
Consortium (CDISC)
 CDISC is a global, open, multidisciplinary, non-profit
organization that has established standards to support
the acquisition, exchange, submission and archive of
clinical research data and metadata.
 Leads the development of standards that improve
efficiency while supporting the scientific nature of clinical
research.
 Recognizes the ultimate goal of creating regulatory
submissions that allow for flexibility in scientific content
and are easily.
Standard Data Tabulation Model
(SDTM)
 SDTM defines a standard structure for study data
tabulations (datasets) that are to be submitted to a
regulatory authority such as the Food & Drug
Administration (FDA).
 Benefits of SDTM:
SDTM allows reviewers at the FDA to develop a
repository of all submitted studies and create stand
alone tools to access, manipulate and view the study
data.
SDTM Implementation Guide and Its
Versions
 Study Data Tabulation Model Implementation Guide
(SDMIG) for Clinical Trials is prepared by Submission
Data Standards (SDS) Team.
 Implementation guide has two different versions:
i) SDTMIG V3.1.1
ii) SDTMIG V3.1.2 (newest and preferred)
Continued….
 SDTM Implementation guide describes the general
conceptual model for preparing clinical study data that
is submitted to regulatory authorities. The SDTMIG V3.1.2
provides specific domain models, assumptions, business
rules, and examples for preparing standard tabulation
datasets.
SDTM Fundamentals
• SDTM Variable Classification:
1.) Identifier : These are the variable which
identifies the study, subject involved,
domain and sequence number.
2.) Topic : This specifies the focus of the observations
3.) Timing : Describes the timing of an observations
4.) Qualifier : Contains additional text, values,
or results which helps describes the
observations
Continued….
 5.) Rule: This explains the algorithm or calculation
involved to derived date- times or visits. This is mainly
used in Trial Design Domain.
 Classification of Qualifier Variables:
Qualifier is further categorized into five classes:
1.) Grouping Qualifier : These are used to group together
a collection of observation. Example: LBCAT.
2.) Result Qualifier : This describes the specific result
associated with Topic variables for a finding.
Continued….
 3.) Synonym Qualifier: This variable contains alternate
value name for a particular observation. For ex:
AETERM, AEMODIFY and AEDECOD.
 4.) Record Qualifier: This defines additional attributes of
an observations in a record. Ex: AEREL.
 5.) Variable Qualifier: This variable further describes the
value of a observation in a record. Ex: Lab Units
(LBORRESU).
Observation Class
Datasets containing observations are classified into three
classes:
 Intervention: This class captures information regarding
investigational treatment, therapeutic treatment and
procedures. Ex: CM, EX, SU.
 Events: This class captures occurrences and incidents
occurred during study trial. Ex: AE, MH, DS, DV.
 Findings: This class captures observation resulting from
planned evaluation. Ex: IE, LB, QS, PE, PC, PP, SC, VS.
Special Purpose Domain:
Special Purpose Domain:
 Include subject level data and do not conform to any of
the three classes of observation datasets.
 Examples are:
– Demographics (DM)
– Comments (CO)
– Subject Visits (SV)
– Subject Elements (SE)
Trial Design Model
Trial Design: The design of a clinical trial is a plan for what
assessments will be done to subjects and what data will
be collected during the trial to address the trial's
objectives.
 These datasets fall under this model:
– Trial Arms (TA)
– Trial Elements (TE)
– Trial Visits (TV)
– Trial Inclusion/Exclusion Criteria (TI)
– Trial Summary Information (TS)
Special Purpose Relationship Datasets
 Supplemental Qualifiers – SUPPQUAL:
Suppqual datasets are used to capture non standard
variables and their association to parent records.
• Relate Records – RELREC:
RELREC is used to describe the relationship between
records in two or more dataset. For ex: Adverse Event
record related to the Concomitant medication.
Continued….
 Supplemental Qualifiers – SUPPQUAL:
Supplemental Qualifiers are always created in the
following situation.
1.) Availability of non SDTM standard data which has
study data but cannot be used in the parent domain.
For ex: PE abnormal findings are in SUPPPE
Continued….
2.) Any dataset in which SDTM variable has text value
exceeding the length of 200 character limit. Text
value is split such that characters 1- 200 are in the
parent domain and characters >200 go into the
Suppqual domain.
Only exception in this case: Trial Inclusion/Exclusion
(TI) domain. If variable IETEST >200, then the
remaining part of text will go into metadata and will
linked to the Define.xml.
Continued….
 RELREC is created only per sponsor’s request for the
following cases.
1.) Information collected about relationship between
concomitant medication and Adverse Event for an
observation.
2.) Any information which has link between
multiple datasets and has a scientific rationale behind
the link.
Sponsor Defined or Custom Domain
 These are the domains usually created in any of the
study trial, when we encounter data which is of non
SDTM standard and cannot be included in any of the
SDTM domain. To include this non SDTM standard data
into the study domains, sponsor defined or custom
domains are created.
 Naming of these domains is also sponsor dependent, but
the first letter for these domains assigned according to
their observation class defined on next slide:
Continued….
 Intervention = X-
 Events = Y-
 Findings = Z-
 According to the data available, we can decide under
which observation class particular data resides and we
can term the name accordingly.
 For ex: If we have any kind of assessment data involved.
So assessments provides us with finding of new data
information, so dataset can be assigned as ZA.
Metadata Contents and Attributes
 Core Variables:
a.) Required: These variable must be present in
the dataset and cannot be null for any record.
b.) Expected: These variable must be present in
the dataset but can have a null value.
c.) Permissible: These variable should be included in
variable appropriately and when data is collected.
If all records have a null value, then this variable
should be dropped.
Controlled Terminology
 Controlled Terminology is defined as the terminology
that controls the value of any variable. (See Appendix C,
Page 271 SDTMIG 3.1.2).
 In almost all of SDTM domains, there are some variables
which always have controlled terminology associated
with them. If any variable is defined in the SDTMIG with
the Controlled Terms or Formats as ACN, NY, STERF,
NCOMPLT etc., then all the values of this variable must
be populated using the Controlled terminology.
Continued….
TerminologySDTM Terminology.xls
• This file consist of all value of controlled terminology
for SDTM variables and its synonym values. While
creating SDTM domain programmer must check
the value for controlled variable in the file and then
provide responses.
Lab_controlled_terminology.xls
Microsoft Excel
Worksheet
Microsoft Excel
Worksheet
Date and Time variable
 --DTC and –STDTC :
All timing variable –DTC and –STDTC variable fall into
either permissible or expected category depending on
dataset. As per definition these variable are allowed to
have null records. As per CDISC guidelines all timing
variable must be presented in ISO 8601 format in all of
the SDTM domain.
ISO 8601 Format
• ISO 8601 Format:
As per the FDA guidelines all the dates available in
SDTM dataset must follow the following format for the
date and time presentation in variables such as --DTC
and --STDTC.
YYYY-MM-DDTHH:MM:SS
• Also as per the format, value of this variable must be a
character value.
ISO 8601 Duration Values
 In any case possible, where instead of dates and time, we
encountered the value in the following way for example
as shown in the column label Duration recorded then
values must be recorded as shown in the column on right
labeled as –DUR value.
 Duration recorded --DUR value
2 Years P2Y
10 Weeks P10W
3 Months 10 days P3M10D
2 hours before RFSTDTC -PT2H*
References:
 www.cdisc.org
 http://www.cancer.gov/cancertopics/terminologyresource
s/CDISC
Questions??

Mais conteúdo relacionado

Mais procurados

SDTM modelling: from study protocol to SDTM-compliant datasets
SDTM modelling: from study protocol to SDTM-compliant datasets SDTM modelling: from study protocol to SDTM-compliant datasets
SDTM modelling: from study protocol to SDTM-compliant datasets Angelo Tinazzi
 
SDTM - Adverse Events Vs. Clinical Events
SDTM - Adverse Events Vs. Clinical EventsSDTM - Adverse Events Vs. Clinical Events
SDTM - Adverse Events Vs. Clinical EventsVijayaraghava Karpurapu
 
Metadata and ADaM
Metadata and ADaMMetadata and ADaM
Metadata and ADaMKevin Lee
 
Post-lock Data Flow: From CRF to FDA
Post-lock Data Flow: From CRF to FDAPost-lock Data Flow: From CRF to FDA
Post-lock Data Flow: From CRF to FDABrook White, PMP
 
CLINICAL STUDY REPORT - IN-TEXT TABLES, TABLES FIGURES AND GRAPHS, PATIENT AN...
CLINICAL STUDY REPORT - IN-TEXT TABLES, TABLES FIGURES AND GRAPHS, PATIENT AN...CLINICAL STUDY REPORT - IN-TEXT TABLES, TABLES FIGURES AND GRAPHS, PATIENT AN...
CLINICAL STUDY REPORT - IN-TEXT TABLES, TABLES FIGURES AND GRAPHS, PATIENT AN...Angelo Tinazzi
 
A Systematic Review of ADaM IG Interpretation
A Systematic Review of ADaM IG InterpretationA Systematic Review of ADaM IG Interpretation
A Systematic Review of ADaM IG InterpretationAngelo Tinazzi
 
Finding everything about findings about (fa)
Finding everything about findings about (fa)Finding everything about findings about (fa)
Finding everything about findings about (fa)Ram Gali
 
CDISC SDTM and ADaM for survival data
CDISC SDTM and ADaM for survival dataCDISC SDTM and ADaM for survival data
CDISC SDTM and ADaM for survival dataAngelo Tinazzi
 
Study data tabulation model
Study data tabulation modelStudy data tabulation model
Study data tabulation modelrahulrabbit
 
Clinical Data Management
Clinical Data ManagementClinical Data Management
Clinical Data ManagementDABBETA DIVYA
 
CDISC's CDASH and SDTM: Why You Need Both!
CDISC's CDASH and SDTM: Why You Need Both!CDISC's CDASH and SDTM: Why You Need Both!
CDISC's CDASH and SDTM: Why You Need Both!Kit Howard
 
How to build ADaM BDS dataset from mock up table
How to build ADaM BDS dataset from mock up tableHow to build ADaM BDS dataset from mock up table
How to build ADaM BDS dataset from mock up tableKevin Lee
 
A complex ADaM dataset - three different ways to create one
A complex ADaM dataset - three different ways to create oneA complex ADaM dataset - three different ways to create one
A complex ADaM dataset - three different ways to create oneKevin Lee
 
A Roadmap for SAS Programmers to Clinical Statistical Programming
A Roadmap for SAS Programmers to Clinical Statistical ProgrammingA Roadmap for SAS Programmers to Clinical Statistical Programming
A Roadmap for SAS Programmers to Clinical Statistical ProgrammingMohammad Majharul Alam
 
Clinical data management
Clinical data managementClinical data management
Clinical data managementGaurav Sharma
 
Introduction to clinical sas programming
Introduction to clinical sas programmingIntroduction to clinical sas programming
Introduction to clinical sas programmingray4hz
 

Mais procurados (20)

SDTM modelling: from study protocol to SDTM-compliant datasets
SDTM modelling: from study protocol to SDTM-compliant datasets SDTM modelling: from study protocol to SDTM-compliant datasets
SDTM modelling: from study protocol to SDTM-compliant datasets
 
CDISC-CDASH
CDISC-CDASHCDISC-CDASH
CDISC-CDASH
 
SDTM - Adverse Events Vs. Clinical Events
SDTM - Adverse Events Vs. Clinical EventsSDTM - Adverse Events Vs. Clinical Events
SDTM - Adverse Events Vs. Clinical Events
 
Metadata and ADaM
Metadata and ADaMMetadata and ADaM
Metadata and ADaM
 
Post-lock Data Flow: From CRF to FDA
Post-lock Data Flow: From CRF to FDAPost-lock Data Flow: From CRF to FDA
Post-lock Data Flow: From CRF to FDA
 
CLINICAL STUDY REPORT - IN-TEXT TABLES, TABLES FIGURES AND GRAPHS, PATIENT AN...
CLINICAL STUDY REPORT - IN-TEXT TABLES, TABLES FIGURES AND GRAPHS, PATIENT AN...CLINICAL STUDY REPORT - IN-TEXT TABLES, TABLES FIGURES AND GRAPHS, PATIENT AN...
CLINICAL STUDY REPORT - IN-TEXT TABLES, TABLES FIGURES AND GRAPHS, PATIENT AN...
 
What We Need to Know About CDISC
What We Need to Know About CDISCWhat We Need to Know About CDISC
What We Need to Know About CDISC
 
A Systematic Review of ADaM IG Interpretation
A Systematic Review of ADaM IG InterpretationA Systematic Review of ADaM IG Interpretation
A Systematic Review of ADaM IG Interpretation
 
Finding everything about findings about (fa)
Finding everything about findings about (fa)Finding everything about findings about (fa)
Finding everything about findings about (fa)
 
CDISC SDTM and ADaM for survival data
CDISC SDTM and ADaM for survival dataCDISC SDTM and ADaM for survival data
CDISC SDTM and ADaM for survival data
 
Study data tabulation model
Study data tabulation modelStudy data tabulation model
Study data tabulation model
 
regulatory.pptx
regulatory.pptxregulatory.pptx
regulatory.pptx
 
Clinical Data Management
Clinical Data ManagementClinical Data Management
Clinical Data Management
 
CDISC's CDASH and SDTM: Why You Need Both!
CDISC's CDASH and SDTM: Why You Need Both!CDISC's CDASH and SDTM: Why You Need Both!
CDISC's CDASH and SDTM: Why You Need Both!
 
How to build ADaM BDS dataset from mock up table
How to build ADaM BDS dataset from mock up tableHow to build ADaM BDS dataset from mock up table
How to build ADaM BDS dataset from mock up table
 
A complex ADaM dataset - three different ways to create one
A complex ADaM dataset - three different ways to create oneA complex ADaM dataset - three different ways to create one
A complex ADaM dataset - three different ways to create one
 
Introduction to clinical sas
Introduction to clinical sasIntroduction to clinical sas
Introduction to clinical sas
 
A Roadmap for SAS Programmers to Clinical Statistical Programming
A Roadmap for SAS Programmers to Clinical Statistical ProgrammingA Roadmap for SAS Programmers to Clinical Statistical Programming
A Roadmap for SAS Programmers to Clinical Statistical Programming
 
Clinical data management
Clinical data managementClinical data management
Clinical data management
 
Introduction to clinical sas programming
Introduction to clinical sas programmingIntroduction to clinical sas programming
Introduction to clinical sas programming
 

Destaque

INTERPRETING CDISC ADaM IG THROUGH USERS INTERPRETATION
INTERPRETING CDISC ADaM IG THROUGH USERS INTERPRETATIONINTERPRETING CDISC ADaM IG THROUGH USERS INTERPRETATION
INTERPRETING CDISC ADaM IG THROUGH USERS INTERPRETATIONAngelo Tinazzi
 
Top 10 clinical data manager interview questions and answers
Top 10 clinical data manager interview questions and answersTop 10 clinical data manager interview questions and answers
Top 10 clinical data manager interview questions and answerscadderlux
 
Clinical Data Management Training @ Gratisol Labs
Clinical Data Management Training @ Gratisol LabsClinical Data Management Training @ Gratisol Labs
Clinical Data Management Training @ Gratisol LabsGratisol Labs
 
Implementation of CDISC ADAM in The Pharmacokinetics Department
Implementation of CDISC ADAM in The Pharmacokinetics DepartmentImplementation of CDISC ADAM in The Pharmacokinetics Department
Implementation of CDISC ADAM in The Pharmacokinetics DepartmentSGS
 
Clinical data management
Clinical data managementClinical data management
Clinical data managementUpendra Agarwal
 
The application of STDM in a no-profit and disease specific organisation - CD...
The application of STDM in a no-profit and disease specific organisation - CD...The application of STDM in a no-profit and disease specific organisation - CD...
The application of STDM in a no-profit and disease specific organisation - CD...Angelo Tinazzi
 
Base sas 2 sas windowing environment
Base sas 2  sas windowing environmentBase sas 2  sas windowing environment
Base sas 2 sas windowing environmentsinghvikram549
 
How to validate sdtm suppqual
How to validate sdtm suppqualHow to validate sdtm suppqual
How to validate sdtm suppqualKevin Lee
 
Strategies for Implementing CDISC
Strategies for Implementing CDISCStrategies for Implementing CDISC
Strategies for Implementing CDISCjbarag
 
AkrodouY-Week7 Project Part 2a
AkrodouY-Week7 Project Part 2aAkrodouY-Week7 Project Part 2a
AkrodouY-Week7 Project Part 2aYawo Akrodou
 
Patients Driving Health Innovation - Kevin Whelan Fighting Blindness - Octobe...
Patients Driving Health Innovation - Kevin Whelan Fighting Blindness - Octobe...Patients Driving Health Innovation - Kevin Whelan Fighting Blindness - Octobe...
Patients Driving Health Innovation - Kevin Whelan Fighting Blindness - Octobe...ipposi
 
Personalized Medicine in clinical drug development: opportunities for Biomedi...
Personalized Medicine in clinical drug development: opportunities for Biomedi...Personalized Medicine in clinical drug development: opportunities for Biomedi...
Personalized Medicine in clinical drug development: opportunities for Biomedi...John Cai
 

Destaque (13)

INTERPRETING CDISC ADaM IG THROUGH USERS INTERPRETATION
INTERPRETING CDISC ADaM IG THROUGH USERS INTERPRETATIONINTERPRETING CDISC ADaM IG THROUGH USERS INTERPRETATION
INTERPRETING CDISC ADaM IG THROUGH USERS INTERPRETATION
 
Top 10 clinical data manager interview questions and answers
Top 10 clinical data manager interview questions and answersTop 10 clinical data manager interview questions and answers
Top 10 clinical data manager interview questions and answers
 
Clinical Data Management Training @ Gratisol Labs
Clinical Data Management Training @ Gratisol LabsClinical Data Management Training @ Gratisol Labs
Clinical Data Management Training @ Gratisol Labs
 
Implementation of CDISC ADAM in The Pharmacokinetics Department
Implementation of CDISC ADAM in The Pharmacokinetics DepartmentImplementation of CDISC ADAM in The Pharmacokinetics Department
Implementation of CDISC ADAM in The Pharmacokinetics Department
 
Clinical data management
Clinical data managementClinical data management
Clinical data management
 
SDTM and CDASH Training with Shannon Labout
SDTM and CDASH Training with Shannon LaboutSDTM and CDASH Training with Shannon Labout
SDTM and CDASH Training with Shannon Labout
 
The application of STDM in a no-profit and disease specific organisation - CD...
The application of STDM in a no-profit and disease specific organisation - CD...The application of STDM in a no-profit and disease specific organisation - CD...
The application of STDM in a no-profit and disease specific organisation - CD...
 
Base sas 2 sas windowing environment
Base sas 2  sas windowing environmentBase sas 2  sas windowing environment
Base sas 2 sas windowing environment
 
How to validate sdtm suppqual
How to validate sdtm suppqualHow to validate sdtm suppqual
How to validate sdtm suppqual
 
Strategies for Implementing CDISC
Strategies for Implementing CDISCStrategies for Implementing CDISC
Strategies for Implementing CDISC
 
AkrodouY-Week7 Project Part 2a
AkrodouY-Week7 Project Part 2aAkrodouY-Week7 Project Part 2a
AkrodouY-Week7 Project Part 2a
 
Patients Driving Health Innovation - Kevin Whelan Fighting Blindness - Octobe...
Patients Driving Health Innovation - Kevin Whelan Fighting Blindness - Octobe...Patients Driving Health Innovation - Kevin Whelan Fighting Blindness - Octobe...
Patients Driving Health Innovation - Kevin Whelan Fighting Blindness - Octobe...
 
Personalized Medicine in clinical drug development: opportunities for Biomedi...
Personalized Medicine in clinical drug development: opportunities for Biomedi...Personalized Medicine in clinical drug development: opportunities for Biomedi...
Personalized Medicine in clinical drug development: opportunities for Biomedi...
 

Semelhante a CDISC SDTM Domain Presentation

cdiscsdtmtrainingpresentation-12900042423172-phpapp01.ppt
cdiscsdtmtrainingpresentation-12900042423172-phpapp01.pptcdiscsdtmtrainingpresentation-12900042423172-phpapp01.ppt
cdiscsdtmtrainingpresentation-12900042423172-phpapp01.pptpoonamshukla311
 
HCLSIG$$Drug_Safety_and_Efficacy$CDISCs_SDTM_basics.ppt
HCLSIG$$Drug_Safety_and_Efficacy$CDISCs_SDTM_basics.pptHCLSIG$$Drug_Safety_and_Efficacy$CDISCs_SDTM_basics.ppt
HCLSIG$$Drug_Safety_and_Efficacy$CDISCs_SDTM_basics.pptMadeeshShaik
 
CDISC2RDF poster for Conference on Data Integration in the Life Sciences 2013
CDISC2RDF poster for Conference on Data Integration in the Life Sciences 2013CDISC2RDF poster for Conference on Data Integration in the Life Sciences 2013
CDISC2RDF poster for Conference on Data Integration in the Life Sciences 2013Kerstin Forsberg
 
Validation Tools and Results Bay Area PharmaSUG 2015-02-10 01
Validation Tools and Results Bay Area PharmaSUG 2015-02-10 01Validation Tools and Results Bay Area PharmaSUG 2015-02-10 01
Validation Tools and Results Bay Area PharmaSUG 2015-02-10 01David Borbas
 
Query-porcessing-& Query optimization
Query-porcessing-& Query optimizationQuery-porcessing-& Query optimization
Query-porcessing-& Query optimizationSaranya Natarajan
 
Designing and launching the Clinical Reference Library
Designing and launching the Clinical Reference LibraryDesigning and launching the Clinical Reference Library
Designing and launching the Clinical Reference LibraryKerstin Forsberg
 
Dataset description: DCAT and other vocabularies
Dataset description: DCAT and other vocabulariesDataset description: DCAT and other vocabularies
Dataset description: DCAT and other vocabulariesValeria Pesce
 
Dats nih-dccpc-kc7-april2018-prs-uoxf
Dats  nih-dccpc-kc7-april2018-prs-uoxfDats  nih-dccpc-kc7-april2018-prs-uoxf
Dats nih-dccpc-kc7-april2018-prs-uoxfPhilippe Rocca-Serra
 
Paper presentations: UK e-science AHM meeting, 2005
Paper presentations: UK e-science AHM meeting, 2005Paper presentations: UK e-science AHM meeting, 2005
Paper presentations: UK e-science AHM meeting, 2005Paolo Missier
 
Developing MDR Requirements and Operational Implementation
Developing MDR Requirements and Operational ImplementationDeveloping MDR Requirements and Operational Implementation
Developing MDR Requirements and Operational Implementationd-Wise Technologies
 
Leveraging Oracle's Life Sciences Data Hub to Enable Dynamic Cross-Study Anal...
Leveraging Oracle's Life Sciences Data Hub to Enable Dynamic Cross-Study Anal...Leveraging Oracle's Life Sciences Data Hub to Enable Dynamic Cross-Study Anal...
Leveraging Oracle's Life Sciences Data Hub to Enable Dynamic Cross-Study Anal...Perficient
 
UNIT - 1 Part 2: Data Warehousing and Data Mining
UNIT - 1 Part 2: Data Warehousing and Data MiningUNIT - 1 Part 2: Data Warehousing and Data Mining
UNIT - 1 Part 2: Data Warehousing and Data MiningNandakumar P
 
Standards for clinical research data - steps to an information model (CRIM).
Standards for clinical research data - steps to an information model (CRIM).Standards for clinical research data - steps to an information model (CRIM).
Standards for clinical research data - steps to an information model (CRIM).Wolfgang Kuchinke
 
Etl Overview (Extract, Transform, And Load)
Etl Overview (Extract, Transform, And Load)Etl Overview (Extract, Transform, And Load)
Etl Overview (Extract, Transform, And Load)LizLavaveshkul
 
Leveraging CEDAR workbench for ontology-linked submission of adaptive immune ...
Leveraging CEDAR workbench for ontology-linked submission of adaptive immune ...Leveraging CEDAR workbench for ontology-linked submission of adaptive immune ...
Leveraging CEDAR workbench for ontology-linked submission of adaptive immune ...Syed Ahmad Chan Bukhari, PhD
 
Leveraging the CEDAR Workbench for Ontology-linked Submission of Adaptive Imm...
Leveraging the CEDAR Workbench for Ontology-linked Submission of Adaptive Imm...Leveraging the CEDAR Workbench for Ontology-linked Submission of Adaptive Imm...
Leveraging the CEDAR Workbench for Ontology-linked Submission of Adaptive Imm...Ahmad C. Bukhari
 

Semelhante a CDISC SDTM Domain Presentation (20)

cdiscsdtmtrainingpresentation-12900042423172-phpapp01.ppt
cdiscsdtmtrainingpresentation-12900042423172-phpapp01.pptcdiscsdtmtrainingpresentation-12900042423172-phpapp01.ppt
cdiscsdtmtrainingpresentation-12900042423172-phpapp01.ppt
 
HCLSIG$$Drug_Safety_and_Efficacy$CDISCs_SDTM_basics.ppt
HCLSIG$$Drug_Safety_and_Efficacy$CDISCs_SDTM_basics.pptHCLSIG$$Drug_Safety_and_Efficacy$CDISCs_SDTM_basics.ppt
HCLSIG$$Drug_Safety_and_Efficacy$CDISCs_SDTM_basics.ppt
 
CDISCs_SDTM_basics.ppt
CDISCs_SDTM_basics.pptCDISCs_SDTM_basics.ppt
CDISCs_SDTM_basics.ppt
 
CDISC2RDF poster for Conference on Data Integration in the Life Sciences 2013
CDISC2RDF poster for Conference on Data Integration in the Life Sciences 2013CDISC2RDF poster for Conference on Data Integration in the Life Sciences 2013
CDISC2RDF poster for Conference on Data Integration in the Life Sciences 2013
 
trail design.pdf
trail design.pdftrail design.pdf
trail design.pdf
 
Validation Tools and Results Bay Area PharmaSUG 2015-02-10 01
Validation Tools and Results Bay Area PharmaSUG 2015-02-10 01Validation Tools and Results Bay Area PharmaSUG 2015-02-10 01
Validation Tools and Results Bay Area PharmaSUG 2015-02-10 01
 
Query-porcessing-& Query optimization
Query-porcessing-& Query optimizationQuery-porcessing-& Query optimization
Query-porcessing-& Query optimization
 
Data Mining
Data MiningData Mining
Data Mining
 
Designing and launching the Clinical Reference Library
Designing and launching the Clinical Reference LibraryDesigning and launching the Clinical Reference Library
Designing and launching the Clinical Reference Library
 
Dataset description: DCAT and other vocabularies
Dataset description: DCAT and other vocabulariesDataset description: DCAT and other vocabularies
Dataset description: DCAT and other vocabularies
 
Dats nih-dccpc-kc7-april2018-prs-uoxf
Dats  nih-dccpc-kc7-april2018-prs-uoxfDats  nih-dccpc-kc7-april2018-prs-uoxf
Dats nih-dccpc-kc7-april2018-prs-uoxf
 
Paper presentations: UK e-science AHM meeting, 2005
Paper presentations: UK e-science AHM meeting, 2005Paper presentations: UK e-science AHM meeting, 2005
Paper presentations: UK e-science AHM meeting, 2005
 
Developing MDR Requirements and Operational Implementation
Developing MDR Requirements and Operational ImplementationDeveloping MDR Requirements and Operational Implementation
Developing MDR Requirements and Operational Implementation
 
Leveraging Oracle's Life Sciences Data Hub to Enable Dynamic Cross-Study Anal...
Leveraging Oracle's Life Sciences Data Hub to Enable Dynamic Cross-Study Anal...Leveraging Oracle's Life Sciences Data Hub to Enable Dynamic Cross-Study Anal...
Leveraging Oracle's Life Sciences Data Hub to Enable Dynamic Cross-Study Anal...
 
UNIT - 1 Part 2: Data Warehousing and Data Mining
UNIT - 1 Part 2: Data Warehousing and Data MiningUNIT - 1 Part 2: Data Warehousing and Data Mining
UNIT - 1 Part 2: Data Warehousing and Data Mining
 
Standards for clinical research data - steps to an information model (CRIM).
Standards for clinical research data - steps to an information model (CRIM).Standards for clinical research data - steps to an information model (CRIM).
Standards for clinical research data - steps to an information model (CRIM).
 
Etl Overview (Extract, Transform, And Load)
Etl Overview (Extract, Transform, And Load)Etl Overview (Extract, Transform, And Load)
Etl Overview (Extract, Transform, And Load)
 
Leveraging CEDAR workbench for ontology-linked submission of adaptive immune ...
Leveraging CEDAR workbench for ontology-linked submission of adaptive immune ...Leveraging CEDAR workbench for ontology-linked submission of adaptive immune ...
Leveraging CEDAR workbench for ontology-linked submission of adaptive immune ...
 
Leveraging the CEDAR Workbench for Ontology-linked Submission of Adaptive Imm...
Leveraging the CEDAR Workbench for Ontology-linked Submission of Adaptive Imm...Leveraging the CEDAR Workbench for Ontology-linked Submission of Adaptive Imm...
Leveraging the CEDAR Workbench for Ontology-linked Submission of Adaptive Imm...
 
D-5436
D-5436D-5436
D-5436
 

Último

Cannabis Legalization World Map: 2024 Updated
Cannabis Legalization World Map: 2024 UpdatedCannabis Legalization World Map: 2024 Updated
Cannabis Legalization World Map: 2024 UpdatedCannaBusinessPlans
 
Structuring and Writing DRL Mckinsey (1).pdf
Structuring and Writing DRL Mckinsey (1).pdfStructuring and Writing DRL Mckinsey (1).pdf
Structuring and Writing DRL Mckinsey (1).pdflaloo_007
 
joint cost.pptx COST ACCOUNTING Sixteenth Edition ...
joint cost.pptx  COST ACCOUNTING  Sixteenth Edition                          ...joint cost.pptx  COST ACCOUNTING  Sixteenth Edition                          ...
joint cost.pptx COST ACCOUNTING Sixteenth Edition ...NadhimTaha
 
Paradip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Paradip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDINGParadip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Paradip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDINGpr788182
 
PHX May 2024 Corporate Presentation Final
PHX May 2024 Corporate Presentation FinalPHX May 2024 Corporate Presentation Final
PHX May 2024 Corporate Presentation FinalPanhandleOilandGas
 
BeMetals Investor Presentation_May 3, 2024.pdf
BeMetals Investor Presentation_May 3, 2024.pdfBeMetals Investor Presentation_May 3, 2024.pdf
BeMetals Investor Presentation_May 3, 2024.pdfDerekIwanaka1
 
New 2024 Cannabis Edibles Investor Pitch Deck Template
New 2024 Cannabis Edibles Investor Pitch Deck TemplateNew 2024 Cannabis Edibles Investor Pitch Deck Template
New 2024 Cannabis Edibles Investor Pitch Deck TemplateCannaBusinessPlans
 
Call 7737669865 Vadodara Call Girls Service at your Door Step Available All Time
Call 7737669865 Vadodara Call Girls Service at your Door Step Available All TimeCall 7737669865 Vadodara Call Girls Service at your Door Step Available All Time
Call 7737669865 Vadodara Call Girls Service at your Door Step Available All Timegargpaaro
 
Putting the SPARK into Virtual Training.pptx
Putting the SPARK into Virtual Training.pptxPutting the SPARK into Virtual Training.pptx
Putting the SPARK into Virtual Training.pptxCynthia Clay
 
Phases of Negotiation .pptx
 Phases of Negotiation .pptx Phases of Negotiation .pptx
Phases of Negotiation .pptxnandhinijagan9867
 
Over the Top (OTT) Market Size & Growth Outlook 2024-2030
Over the Top (OTT) Market Size & Growth Outlook 2024-2030Over the Top (OTT) Market Size & Growth Outlook 2024-2030
Over the Top (OTT) Market Size & Growth Outlook 2024-2030tarushabhavsar
 
Falcon's Invoice Discounting: Your Path to Prosperity
Falcon's Invoice Discounting: Your Path to ProsperityFalcon's Invoice Discounting: Your Path to Prosperity
Falcon's Invoice Discounting: Your Path to Prosperityhemanthkumar470700
 
Mifepristone Available in Muscat +918761049707^^ €€ Buy Abortion Pills in Oman
Mifepristone Available in Muscat +918761049707^^ €€ Buy Abortion Pills in OmanMifepristone Available in Muscat +918761049707^^ €€ Buy Abortion Pills in Oman
Mifepristone Available in Muscat +918761049707^^ €€ Buy Abortion Pills in Omaninstagramfab782445
 
Power point presentation on enterprise performance management
Power point presentation on enterprise performance managementPower point presentation on enterprise performance management
Power point presentation on enterprise performance managementVaishnaviGunji
 
Famous Olympic Siblings from the 21st Century
Famous Olympic Siblings from the 21st CenturyFamous Olympic Siblings from the 21st Century
Famous Olympic Siblings from the 21st Centuryrwgiffor
 
Katrina Personal Brand Project and portfolio 1
Katrina Personal Brand Project and portfolio 1Katrina Personal Brand Project and portfolio 1
Katrina Personal Brand Project and portfolio 1kcpayne
 
Buy Verified TransferWise Accounts From Seosmmearth
Buy Verified TransferWise Accounts From SeosmmearthBuy Verified TransferWise Accounts From Seosmmearth
Buy Verified TransferWise Accounts From SeosmmearthBuy Verified Binance Account
 
TVB_The Vietnam Believer Newsletter_May 6th, 2024_ENVol. 006.pdf
TVB_The Vietnam Believer Newsletter_May 6th, 2024_ENVol. 006.pdfTVB_The Vietnam Believer Newsletter_May 6th, 2024_ENVol. 006.pdf
TVB_The Vietnam Believer Newsletter_May 6th, 2024_ENVol. 006.pdfbelieveminhh
 
Lundin Gold - Q1 2024 Conference Call Presentation (Revised)
Lundin Gold - Q1 2024 Conference Call Presentation (Revised)Lundin Gold - Q1 2024 Conference Call Presentation (Revised)
Lundin Gold - Q1 2024 Conference Call Presentation (Revised)Adnet Communications
 

Último (20)

Cannabis Legalization World Map: 2024 Updated
Cannabis Legalization World Map: 2024 UpdatedCannabis Legalization World Map: 2024 Updated
Cannabis Legalization World Map: 2024 Updated
 
Structuring and Writing DRL Mckinsey (1).pdf
Structuring and Writing DRL Mckinsey (1).pdfStructuring and Writing DRL Mckinsey (1).pdf
Structuring and Writing DRL Mckinsey (1).pdf
 
joint cost.pptx COST ACCOUNTING Sixteenth Edition ...
joint cost.pptx  COST ACCOUNTING  Sixteenth Edition                          ...joint cost.pptx  COST ACCOUNTING  Sixteenth Edition                          ...
joint cost.pptx COST ACCOUNTING Sixteenth Edition ...
 
unwanted pregnancy Kit [+918133066128] Abortion Pills IN Dubai UAE Abudhabi
unwanted pregnancy Kit [+918133066128] Abortion Pills IN Dubai UAE Abudhabiunwanted pregnancy Kit [+918133066128] Abortion Pills IN Dubai UAE Abudhabi
unwanted pregnancy Kit [+918133066128] Abortion Pills IN Dubai UAE Abudhabi
 
Paradip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Paradip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDINGParadip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Paradip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
 
PHX May 2024 Corporate Presentation Final
PHX May 2024 Corporate Presentation FinalPHX May 2024 Corporate Presentation Final
PHX May 2024 Corporate Presentation Final
 
BeMetals Investor Presentation_May 3, 2024.pdf
BeMetals Investor Presentation_May 3, 2024.pdfBeMetals Investor Presentation_May 3, 2024.pdf
BeMetals Investor Presentation_May 3, 2024.pdf
 
New 2024 Cannabis Edibles Investor Pitch Deck Template
New 2024 Cannabis Edibles Investor Pitch Deck TemplateNew 2024 Cannabis Edibles Investor Pitch Deck Template
New 2024 Cannabis Edibles Investor Pitch Deck Template
 
Call 7737669865 Vadodara Call Girls Service at your Door Step Available All Time
Call 7737669865 Vadodara Call Girls Service at your Door Step Available All TimeCall 7737669865 Vadodara Call Girls Service at your Door Step Available All Time
Call 7737669865 Vadodara Call Girls Service at your Door Step Available All Time
 
Putting the SPARK into Virtual Training.pptx
Putting the SPARK into Virtual Training.pptxPutting the SPARK into Virtual Training.pptx
Putting the SPARK into Virtual Training.pptx
 
Phases of Negotiation .pptx
 Phases of Negotiation .pptx Phases of Negotiation .pptx
Phases of Negotiation .pptx
 
Over the Top (OTT) Market Size & Growth Outlook 2024-2030
Over the Top (OTT) Market Size & Growth Outlook 2024-2030Over the Top (OTT) Market Size & Growth Outlook 2024-2030
Over the Top (OTT) Market Size & Growth Outlook 2024-2030
 
Falcon's Invoice Discounting: Your Path to Prosperity
Falcon's Invoice Discounting: Your Path to ProsperityFalcon's Invoice Discounting: Your Path to Prosperity
Falcon's Invoice Discounting: Your Path to Prosperity
 
Mifepristone Available in Muscat +918761049707^^ €€ Buy Abortion Pills in Oman
Mifepristone Available in Muscat +918761049707^^ €€ Buy Abortion Pills in OmanMifepristone Available in Muscat +918761049707^^ €€ Buy Abortion Pills in Oman
Mifepristone Available in Muscat +918761049707^^ €€ Buy Abortion Pills in Oman
 
Power point presentation on enterprise performance management
Power point presentation on enterprise performance managementPower point presentation on enterprise performance management
Power point presentation on enterprise performance management
 
Famous Olympic Siblings from the 21st Century
Famous Olympic Siblings from the 21st CenturyFamous Olympic Siblings from the 21st Century
Famous Olympic Siblings from the 21st Century
 
Katrina Personal Brand Project and portfolio 1
Katrina Personal Brand Project and portfolio 1Katrina Personal Brand Project and portfolio 1
Katrina Personal Brand Project and portfolio 1
 
Buy Verified TransferWise Accounts From Seosmmearth
Buy Verified TransferWise Accounts From SeosmmearthBuy Verified TransferWise Accounts From Seosmmearth
Buy Verified TransferWise Accounts From Seosmmearth
 
TVB_The Vietnam Believer Newsletter_May 6th, 2024_ENVol. 006.pdf
TVB_The Vietnam Believer Newsletter_May 6th, 2024_ENVol. 006.pdfTVB_The Vietnam Believer Newsletter_May 6th, 2024_ENVol. 006.pdf
TVB_The Vietnam Believer Newsletter_May 6th, 2024_ENVol. 006.pdf
 
Lundin Gold - Q1 2024 Conference Call Presentation (Revised)
Lundin Gold - Q1 2024 Conference Call Presentation (Revised)Lundin Gold - Q1 2024 Conference Call Presentation (Revised)
Lundin Gold - Q1 2024 Conference Call Presentation (Revised)
 

CDISC SDTM Domain Presentation

  • 1. Combined Data Interchange Standard Consortium (CDISC) Standard Data Tabulation Model Presented By: Ankur Sharma Biostatistical Programmer PAREXEL International, Baltimore, MD, USA
  • 2. Definitions  CDISC : Clinical Data Interchange Standard Consortium  SDTM : Standard Data Tabulation Model  ADaM : Analysis Data Model  SDS : Submission Data Standards  DDT : Data Definition Tables
  • 3. Clinical Data Interchange Standard Consortium (CDISC)  CDISC is a global, open, multidisciplinary, non-profit organization that has established standards to support the acquisition, exchange, submission and archive of clinical research data and metadata.  Leads the development of standards that improve efficiency while supporting the scientific nature of clinical research.  Recognizes the ultimate goal of creating regulatory submissions that allow for flexibility in scientific content and are easily.
  • 4. Standard Data Tabulation Model (SDTM)  SDTM defines a standard structure for study data tabulations (datasets) that are to be submitted to a regulatory authority such as the Food & Drug Administration (FDA).  Benefits of SDTM: SDTM allows reviewers at the FDA to develop a repository of all submitted studies and create stand alone tools to access, manipulate and view the study data.
  • 5. SDTM Implementation Guide and Its Versions  Study Data Tabulation Model Implementation Guide (SDMIG) for Clinical Trials is prepared by Submission Data Standards (SDS) Team.  Implementation guide has two different versions: i) SDTMIG V3.1.1 ii) SDTMIG V3.1.2 (newest and preferred)
  • 6. Continued….  SDTM Implementation guide describes the general conceptual model for preparing clinical study data that is submitted to regulatory authorities. The SDTMIG V3.1.2 provides specific domain models, assumptions, business rules, and examples for preparing standard tabulation datasets.
  • 7. SDTM Fundamentals • SDTM Variable Classification: 1.) Identifier : These are the variable which identifies the study, subject involved, domain and sequence number. 2.) Topic : This specifies the focus of the observations 3.) Timing : Describes the timing of an observations 4.) Qualifier : Contains additional text, values, or results which helps describes the observations
  • 8. Continued….  5.) Rule: This explains the algorithm or calculation involved to derived date- times or visits. This is mainly used in Trial Design Domain.  Classification of Qualifier Variables: Qualifier is further categorized into five classes: 1.) Grouping Qualifier : These are used to group together a collection of observation. Example: LBCAT. 2.) Result Qualifier : This describes the specific result associated with Topic variables for a finding.
  • 9. Continued….  3.) Synonym Qualifier: This variable contains alternate value name for a particular observation. For ex: AETERM, AEMODIFY and AEDECOD.  4.) Record Qualifier: This defines additional attributes of an observations in a record. Ex: AEREL.  5.) Variable Qualifier: This variable further describes the value of a observation in a record. Ex: Lab Units (LBORRESU).
  • 10. Observation Class Datasets containing observations are classified into three classes:  Intervention: This class captures information regarding investigational treatment, therapeutic treatment and procedures. Ex: CM, EX, SU.  Events: This class captures occurrences and incidents occurred during study trial. Ex: AE, MH, DS, DV.  Findings: This class captures observation resulting from planned evaluation. Ex: IE, LB, QS, PE, PC, PP, SC, VS.
  • 11. Special Purpose Domain: Special Purpose Domain:  Include subject level data and do not conform to any of the three classes of observation datasets.  Examples are: – Demographics (DM) – Comments (CO) – Subject Visits (SV) – Subject Elements (SE)
  • 12. Trial Design Model Trial Design: The design of a clinical trial is a plan for what assessments will be done to subjects and what data will be collected during the trial to address the trial's objectives.  These datasets fall under this model: – Trial Arms (TA) – Trial Elements (TE) – Trial Visits (TV) – Trial Inclusion/Exclusion Criteria (TI) – Trial Summary Information (TS)
  • 13. Special Purpose Relationship Datasets  Supplemental Qualifiers – SUPPQUAL: Suppqual datasets are used to capture non standard variables and their association to parent records. • Relate Records – RELREC: RELREC is used to describe the relationship between records in two or more dataset. For ex: Adverse Event record related to the Concomitant medication.
  • 14. Continued….  Supplemental Qualifiers – SUPPQUAL: Supplemental Qualifiers are always created in the following situation. 1.) Availability of non SDTM standard data which has study data but cannot be used in the parent domain. For ex: PE abnormal findings are in SUPPPE
  • 15. Continued…. 2.) Any dataset in which SDTM variable has text value exceeding the length of 200 character limit. Text value is split such that characters 1- 200 are in the parent domain and characters >200 go into the Suppqual domain. Only exception in this case: Trial Inclusion/Exclusion (TI) domain. If variable IETEST >200, then the remaining part of text will go into metadata and will linked to the Define.xml.
  • 16. Continued….  RELREC is created only per sponsor’s request for the following cases. 1.) Information collected about relationship between concomitant medication and Adverse Event for an observation. 2.) Any information which has link between multiple datasets and has a scientific rationale behind the link.
  • 17. Sponsor Defined or Custom Domain  These are the domains usually created in any of the study trial, when we encounter data which is of non SDTM standard and cannot be included in any of the SDTM domain. To include this non SDTM standard data into the study domains, sponsor defined or custom domains are created.  Naming of these domains is also sponsor dependent, but the first letter for these domains assigned according to their observation class defined on next slide:
  • 18. Continued….  Intervention = X-  Events = Y-  Findings = Z-  According to the data available, we can decide under which observation class particular data resides and we can term the name accordingly.  For ex: If we have any kind of assessment data involved. So assessments provides us with finding of new data information, so dataset can be assigned as ZA.
  • 19. Metadata Contents and Attributes  Core Variables: a.) Required: These variable must be present in the dataset and cannot be null for any record. b.) Expected: These variable must be present in the dataset but can have a null value. c.) Permissible: These variable should be included in variable appropriately and when data is collected. If all records have a null value, then this variable should be dropped.
  • 20. Controlled Terminology  Controlled Terminology is defined as the terminology that controls the value of any variable. (See Appendix C, Page 271 SDTMIG 3.1.2).  In almost all of SDTM domains, there are some variables which always have controlled terminology associated with them. If any variable is defined in the SDTMIG with the Controlled Terms or Formats as ACN, NY, STERF, NCOMPLT etc., then all the values of this variable must be populated using the Controlled terminology.
  • 21. Continued…. TerminologySDTM Terminology.xls • This file consist of all value of controlled terminology for SDTM variables and its synonym values. While creating SDTM domain programmer must check the value for controlled variable in the file and then provide responses. Lab_controlled_terminology.xls Microsoft Excel Worksheet Microsoft Excel Worksheet
  • 22. Date and Time variable  --DTC and –STDTC : All timing variable –DTC and –STDTC variable fall into either permissible or expected category depending on dataset. As per definition these variable are allowed to have null records. As per CDISC guidelines all timing variable must be presented in ISO 8601 format in all of the SDTM domain.
  • 23. ISO 8601 Format • ISO 8601 Format: As per the FDA guidelines all the dates available in SDTM dataset must follow the following format for the date and time presentation in variables such as --DTC and --STDTC. YYYY-MM-DDTHH:MM:SS • Also as per the format, value of this variable must be a character value.
  • 24. ISO 8601 Duration Values  In any case possible, where instead of dates and time, we encountered the value in the following way for example as shown in the column label Duration recorded then values must be recorded as shown in the column on right labeled as –DUR value.  Duration recorded --DUR value 2 Years P2Y 10 Weeks P10W 3 Months 10 days P3M10D 2 hours before RFSTDTC -PT2H*